Bio-Techne (TECH) Operating Margin (2009 - 2026)
Bio-Techne's (TECH) quarterly Operating Margin came in at 24.24% in Q1 2026, up 1200.0% year-on-year from 1.86% in Q1 2025, and up 31.71% quarter-over-quarter from 18.41% in Q4 2025.
Bio-Techne (TECH) Operating Margin (2009 - 2026) Analysis & Trends
Bio-Techne's Operating Margin history runs 18 years deep, the most recent figure standing at 24.24% for Q1 2026.
- On a quarterly basis, Operating Margin rose 1200.0% year-over-year to 24.24% in Q1 2026; TTM through Mar 2026 was 12.7%, a 153.0% decrease from a year earlier, with the FY2025 full-year figure at 8.38%, down 945.0% from the prior year.
- Operating Margin rose to 24.24% in Q1 2026 per TECH's latest filing, from 18.41% in the prior quarter.
- Across five years, Operating Margin topped out at 2815.85% in Q3 2022 and bottomed at 7.53% in Q2 2025.
- The 5-year median for Operating Margin is 20.17% (2023), against an average of 183.74%.
- Across the five-year window, Operating Margin surged 279132 bps in 2022 and slumped 279568 bps in 2023, its largest moves.
- Year by year, Operating Margin stood at 25.0% in 2022, then plunged by 44 bps to 13.94% in 2023, then grew by 15 bps to 15.96% in 2024, then increased by 15 bps to 18.41% in 2025, then surged by 32 bps to 24.24% in 2026.
- Per Business Quant, the three latest TECH Operating Margin figures stand at 24.24% (Q1 2026), 18.41% (Q4 2025), and 16.63% (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 16.51% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 38.10% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 17.83% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 31.68% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Bio-Techne | 11.23 Bn | 11.02 Bn | 208.29 Mn | 24.24% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 24.24% |
| Dec 31, 2025 | 18.41% |
| Sep 30, 2025 | 16.63% |
| Jun 30, 2025 | -7.53% |
| Mar 31, 2025 | 12.24% |
| Dec 31, 2024 | 15.96% |
| Sep 30, 2024 | 13.81% |
| Jun 30, 2024 | 14.97% |
| Mar 31, 2024 | 22.08% |
| Dec 31, 2023 | 13.94% |
| Sep 30, 2023 | 20.17% |
| Jun 30, 2023 | 31.37% |
| Mar 31, 2023 | 27.27% |
| Dec 31, 2022 | 25.00% |
| Sep 30, 2022 | 2,815.85% |
| Jun 30, 2022 | 27.95% |
| Mar 31, 2022 | 31.15% |
| Dec 31, 2021 | 23.15% |
| Sep 30, 2021 | 24.53% |
| Jun 30, 2021 | 26.48% |